SUMMARY
Cardiac arrest (CA) followed by cardiopulmonary resuscitation (CPR) is associated with high mortality and poor neurological outcome. We compared the effects of pravastatin and simvastatin on survival and neurofunction in a murine model of CA/CPR. Pravastatin, a hydrophilic statin, increased survival and neurofunction during a 28-day follow-up period. This therapy was associated with improved pulmonary function, reduced pulmonary edema, and increased endothelial cell function in vitro. In contrast, lipophilic simvastatin did not modulate survival but increased pulmonary edema and impaired endothelial cell function. Although pravastatin may display a therapeutic option for post-CA syndrome, the application of simvastatin may require re-evaluation. High mortality rates and impaired neurofunction after cardiac arrest and cardiopulmonary resuscitation (CA/CPR) are ascribed to the occurrence of post-CA syndrome following ROSC. Post-CA syndrome is characterized by response to systemic ischemia, followed by reperfusion injury after CA/CPR. It consists of activation of inflammatory signaling cascades, reactive oxygen species regeneration, changes toward a pro-coagulatory state, attenuation of vascular reactivity, and impaired organ perfusion (7). The brain is at particular risk for parenchymal injury following ischemia and reperfusion due to loss of vascular autoregulation and its low tolerance for ischemia (8) . Neurological deficit from brain injury, thus, accounts for two-thirds of mortality and is the primary obstacle to rehabilitation of patients after CA/CPR (9) .
Statins belong to the most widely prescribed class of drugs around the world. Their use has extended from lowering cholesterol levels to preventing cardiovascular disease in almost any patient over 50 years of age (10) . The drug's success is mainly due to its pleiotropic effects, that is, those beyond its lipid-lowering action. The pleiotropic effects of statins include anti-inflammatory and antioxidant properties and decrease of vascular dysfunction (11) .
As the pleiotropic effects multiplicity address the major hallmarks of post-resuscitation syndrome pathophysiology, we aimed to determine whether application of statins by the time CPR was begun would alter survival and neurofunctional outcome of mice following CA.
There are currently 7 statins on the market. They differ in chemical structure, characteristics, and side effects (12) . Clinical and experimental studies suggest differences of statins in acid form soluble in water (i.e., pravastatin, rosuvastatin, pitavastatin, and fluvastatin) and those in lipophilic lactone form (i.e., simvastatin, atorvastatin, and lovastatin) (13, 14) .
We hypothesized that the potential modulation of survival and neurofunctional outcome after CA/CPR may differ when a hydrophilic statin such as pravastatin or a lipophilic statin such as simvastatin is administered. For the purpose of the study, we used a previously established mouse model of CA/CPR, using a modified sewing machine (15 Bergt et al.
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After the central venous catheter was removed, BLOOD GAS ANALYSIS. An additional set of animals (n ¼ 7 mice/group that received identical treatment as described above) was used, and blood was drawn from the right carotid artery 8 h after resuscitation.
Animals were then sacrificed, and lungs harvested for histological and molecular biological analysis.
ANALYSIS OF PULMONARY EDEMA AND ALVEOLAR LEUKOCYTE INFILTRATION. Animals were sacrificed and lung tissue was fixed in formalin. Following paraffin-embedding, lung tissue slices were stained with hematoxylin-eosin. Alveolar septal wall thickness and number of leukocytes were assessed in 10 random high-power fields per mouse using brightfield
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SURVIVAL OF MICE AFTER CA/CPR. Following CA/ CRP, all mice exhibited ROSC and comparable heart rates, mean arterial blood pressures, and body temperatures (Supplemental Table 1 (Figures 2A and 2B ). This was accompanied by higher arterial oxygen partial pressure (Supplemental Table 4 ). In contrast, simvastatin exerted no beneficial effects on either edema formation or pulmonary function, and histological analysis 
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Pravastatin Improves Outcome After Cardiac Arrest hospital who were experiencing CA). We then chose a 28-day follow-up period of survival and neurofunction of mice after CA/CPR in order to collect data most relevant to patient outcome. With this study design, we showed pravastatin treatment resulted in increased survival and neurofunctional outcome compared to that with saline administration. In contrast, simvastatin did not modulate either outcome but was associated with reduced pulmonary function, increased edema formation, and proinflammatory changes in murine lungs and endothelial cells.
Differences between the effects of lipophilic versus hydrophilic statins in the cardiovascular system have been proposed and studied in experimental models and clinical trials. In isolated rat hearts, pravastatin had more pronounced effects on limiting myocardial infarct size following ischemia than simvastatin (14) . In clinical trials investigating outcome following myocardial infarction, no differences were observed when either pravastatin and atorvastatin or treatment with hydrophilic or lipophilic statins per se were compared in patients' outcomes at 1 and 2 years (13, 22) .
Subgroup analysis of these trials in some cases showed reduced levels of B-type natriuretic peptide in pravastatin-treated patients (13, 23) . Figure 1 .
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